HighTower Advisors’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.7K | Buy |
37,200
+27,000
| +265% | +$30.2K | ﹤0.01% | 3515 |
|
|
2025
Q1 | $8.06K | Hold |
10,200
| – | – | ﹤0.01% | 3483 |
|
|
2024
Q4 | $16.8K | Sell |
10,200
-400
| -4% | -$660 | ﹤0.01% | 3464 |
|
|
2024
Q3 | $37K | Sell |
10,600
-604
| -5% | -$2.11K | ﹤0.01% | 3384 |
|
|
2024
Q2 | $37K | Buy |
11,204
+104
| +0.9% | +$343 | ﹤0.01% | 3282 |
|
|
2024
Q1 | $81K | Buy |
11,100
+200
| +2% | +$1.46K | ﹤0.01% | 3154 |
|
|
2023
Q4 | $40K | Sell |
10,900
-5,071
| -32% | -$18.6K | ﹤0.01% | 3260 |
|
|
2023
Q3 | $33K | Sell |
15,971
-200
| -1% | -$413 | ﹤0.01% | 3211 |
|
|
2023
Q2 | $78K | Sell |
16,171
-485
| -3% | -$2.34K | ﹤0.01% | 3079 |
|
|
2023
Q1 | $94K | Buy |
16,656
+881
| +6% | +$4.97K | ﹤0.01% | 2926 |
|
|
2022
Q4 | $159K | Sell |
15,775
-1,694
| -10% | -$17.1K | ﹤0.01% | 2806 |
|
|
2022
Q3 | $391K | Buy |
17,469
+7,019
| +67% | +$157K | ﹤0.01% | 2173 |
|
|
2022
Q2 | $261K | Sell |
10,450
-7,911
| -43% | -$198K | ﹤0.01% | 2430 |
|
|
2022
Q1 | $714K | Buy |
18,361
+1,016
| +6% | +$39.5K | ﹤0.01% | 1947 |
|
|
2021
Q4 | $1.02M | Buy |
17,345
+4,182
| +32% | +$246K | ﹤0.01% | 1746 |
|
|
2021
Q3 | $779K | Sell |
13,163
-487
| -4% | -$28.8K | ﹤0.01% | 1793 |
|
|
2021
Q2 | $1.19M | Buy |
13,650
+7,098
| +108% | +$617K | ﹤0.01% | 1534 |
|
|
2021
Q1 | $540K | Buy |
+6,552
| New | +$540K | ﹤0.01% | 1922 |
|